Modulation of histone acetylation by garlic sulfur compounds

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 3, 2011, Pages 254-259

  Druesne Pecollo, Nathalie ^a,b   Latino Martel, Paule ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b U 1125 INRA ^*  (France)

Author keywords

Allyl mercaptan; Cancer prevention; Diallyl disulfide; Garlic; Gene expression; Histone acetylation; Histone deacetylase activity; Sulfur compounds

Indexed keywords

2 PROPENE 1 THIOL; ALLICIN; ALLYL SULFIDE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DIALLYL DISULFIDE; DIALLYL SULFONE; GARLIC EXTRACT; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; ORGANOSULFUR DERIVATIVE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ADIPOGENESIS; CANCER PREVENTION; CELL CYCLE REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

EID: 79954509046     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152011795347540     Document Type: Review

References (30)

1. Jenuwein, T.; Allis, C.D. Translating the histone code. Science, 2001, 293(5532), 1074-1080.
2. Felsenfeld, G.; Groudine, M. Controlling the double helix. Nature, 2003, 421(6921), 448-453.
3. Narlikar, G.J.; Fan, H.Y.; Kingston, R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell, 2002, 108(4), 475-87.
4. Haberland, M.; Montgomery, R.L.; Olson, E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet., 2009, 10(1), 32-42.
5. Batty, N.; Malouf, G.G.; Issa, J.P.J. Histone deacetylase inhibitors as anti-neoplastic agents. Cancer Lett., 2009, 280(2), 192-200.
6. Frew, A.J.; Johnstone, R.W.; Bolden, J.E. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Lett., 2009, 280(2), 125-133.
7. Botrugno, O.A.; Santoro, F.; Minucci, S. Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. Cancer Lett., 2009, 280(2), 134-144.
8. Glauben, R.; Sonnenberg, E.; Zeitz, M.; Siegmund, B. HDAC inhibitors in models of inflammation-related tumorigenesis. Cancer Lett., 2009, 280(2), 154-159.
9. Ellis, L.; Hammers, H.; Pili, R. Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett., 2009, 280(2), 145-153.
10. Richon, V.M.; Garcia-Vargas, J.; Hardwick, J.S. Development of vorinostat: current applications and future perspectives for cancer therapy. Cancer Lett., 2009, 280(2), 201-210.
11. Atadja, P. Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges. Cancer Lett., 2009, 280(2), 233-241.
12. Stimson, L.; La Thangue, N.B. Biomarkers for predicting clinical responses to HDAC inhibitors. Cancer Lett., 2009, 280(2), 177-183.
13. Myzak, M.C.; Dashwood, R.H. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr. Drug Targets, 2006, 7(4), 443-452.
14. Nian, H.; Delage, B.; Ho, E.; Dashwood, R.H. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ. Mol. Mutagen., 2009, 50(3), 213-221.
15. Ho, E.; Clarke, J.D.; Dashwood, R.H. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J. Nutr., 2009, 139(12), 2393-2396.
16. Dashwood, R.H.; Ho, E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol., 2007, 17(5), 363-369.
17. Lea, M.A.; Randolph, V.M.; Patel, M. Increased acetylation of histones induced by diallyl disulfide and structurally related molecules. Int. J. Oncol., 1999, 15(2), 347-352.
18. Zhao, J.; Huang, W.G.; He, J.; Tan, H.; Liao, Q.J.; Su, Q. Diallyl disulfide suppresses growth of HL-60 cell through increasing histone acetylation and p21WAF1 expression in vivo and in vitro. Acta Pharmacol. Sin., 2006, 27(11), 1459-1466.
19. Lea, M.A.; Randolph, V.M. Induction of histone acetylation in rat liver and hepatoma by organosulfur compounds including diallyl disulfide. Anticancer Res., 2001, 21(4A), 2841-2846.
20. Druesne, N.; Pagniez, A.; Mayeur, C.; Thomas, M.; Cherbuy, C.; Duée, P.H.; Martel, P.; Chaumontet, C. Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis, 2004, 25(7), 1227-1236.
21. Arunkumar, A.; Vijayababu, M.R.; Gunadharini, N.; Krishnamoorthy, G.; Arunakaran, J. Induction of apoptosis and histone hyperacetylation by diallyl disulfide in prostate cancer cell line PC-3. Cancer Lett., 2007, 251(1), 59-67.
22. Lee, J.H.; Kim, K.A.; Kwon, K.B.; Kim, E.K.; Lee, Y.R.; Song, M.Y.; Koo, J.H.; Ka, S.O.; Park, J.W.; Park, B.H. Diallyl disulfide accelerates adipogenesis in 3T3-L1 cells. Int. J. Mol. Med., 2007, 20(1), 59-64.
23. Nian, H.; Delage, B.; Pinto, J.T.; Dashwood, R.H. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. Carcinogenesis, 2008, 29(9), 1816-1824.
24. Lea, M.A.; Rasheed, M.; Randolph, V.M.; Khan, F.; Shareef, A.; desBordes, C. Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine. Nutr. Cancer, 2002, 43(1), 90-102.
25. Druesne-Pecollo, N.; Chaumontet, C.; Pagniez, A.; Vaugelade, P.; Bruneau, A.; Thomas, M.; Cherbuy, C.; Duée, P.H.; Martel, P. In vivo treatment by diallyl disulfide increases histone acetylation in rat colonocytes. Biochem. Biophys. Res. Commun., 2007, 354(1), 140-147.
26. Lea, M.A.; Randolph, V.M.; Lee, J.E.; desBordes, C. Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate. Int. J. Cancer, 2001, 92(6), 784-789.
27. Druesne-Pecollo, N.; Pagniez, A.; Thomas, M.; Cherbuy, C.; Duée, P.H.; Martel, P.; Chaumontet, C. Diallyl disulfide increases CDKN1A promoter-associated histone acetylation in human colon tumor cell lines. J. Agric. Food Chem., 2006, 54(20), 7503-7507.
28. Lea, M.A.; Ayyala, U.S. Differentiating and growth inhibitory effects of diallyl disulfide on cancer cells. Int. J. Oncol., 1999, 11, 181-185.
29. Robert, V.; Mouillé, B.; Mayeur, C.; Michaud, M.; Blachier, F. Effects of the garlic compound diallyl disulfide on the metabolism, adherence and cell cycle of HT-29 colon carcinoma cells: evidence of sensitive and resistant sub-populations. Carcinogenesis, 2001, 22(8), 1155-1161.
30. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective; AICR: Washington DC, 2007; pp. 93-94.